Reflections on the management of a coronavirus disease 2019 patient with refractory hyperglycemia
Chinese Journal of Endocrinology and Metabolism
; 36(6):512-514, 2020.
Article
in Chinese
| Scopus | ID: covidwho-831373
ABSTRACT
The cause and treatment of refractory hyperglycemia in a critically ill coronavirus disease 2019 (COVID-19) patient during treatment were analyzed retrospectively, indicating that novel coronavirus infection may cause damage to glucose metabolism, so the monitoring and control of blood glucose should be strengthened in clinical treatment. Copyright © 2020 by the Chinese Medical Association.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Language:
Chinese
Journal:
Chinese Journal of Endocrinology and Metabolism
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS